|
Originally published In Press as doi:10.1074/jbc.M304192200 on September 30, 2003
J. Biol. Chem., Vol. 278, Issue 51, 51911-51919, December 19, 2003
Shedding of Membrane Vesicles Mediates Fibroblast Growth Factor-2 Release from Cells*
Simona Taverna ,
Giulio Ghersi ,
Angela Ginestra ,
Salvatrice Rigogliuso ,
Sonia Pecorella ,
Giovanna Alaimo ,
Francesca Saladino ,
Vincenza Dolo ,
Patrizia Dell'Era¶,
Antonio Pavan ,
Giuseppe Pizzolanti||,
Paolo Mignatti**,
Marco Presta¶, and
Maria Letizia Vittorelli   
From the
Dipartimento Biologia Cellulare e dello Sviluppo, Università di Palermo, Palermo 90128, Italy, Dipartimento Medicina Sperimentale Università di L'Aquila, L'Aquila 67100, Italy, ¶Dipartimento Scienze Biomediche e Biotecnologie, Università di Brescia, Brescia 25123, Italy, ||Cattedra di Endocrinologia, Istituto di Clinica Medica, Policlinico di Palermo, Palermo 90128, Italy, **Departments of Surgery and Cell Biology, New York University School of Medicine, New York, New York 10016, and  Centro di OncoBiologia Sperimentale, Viale delle Scienze, Palermo 90128, Italy
Fibroblast growth factor-2 (FGF-2), a polypeptide with regulatory activity on cell growth and differentiation, lacks a conventional secretory signal sequence, and its mechanism of release from cells remains unclear. We characterized the role of extracellular vesicle shedding in FGF-2 release. Viable cells released membrane vesicles in the presence of serum. However, in serum-free medium vesicle shedding was dramatically down-regulated, and the cells did not release FGF-2 activity into their conditioned medium. Addition of serum to serum-starved cells rapidly induced intracellular FGF-2 clustering under the plasma membrane and into granules that colocalized with patches of the cell membrane with typical features of shed vesicle membranes. Shed vesicles carried three FGF-2 isoforms (18, 22, 24 kDa). Addition of vesicles to endothelial cells stimulated chemotaxis and urokinase plasminogen activator production, which were blocked by anti-FGF-2 antibodies. Treatment of intact vesicles with 2.0 M NaCl or heparinase, which release FGF-2 from membrane-bound proteoglycans, did not abolish their stimulatory effect on endothelial cells, indicating that FGF-2 is carried inside vesicles. The comparison of the stimulatory effects of shed vesicles and vesicle-free conditioned medium showed that vesicles represent a major reservoir of FGF-2. Thus, FGF-2 can be released from cells through vesicle shedding.
Received for publication, April 22, 2003
, and in revised form, September 26, 2003.
* This work was supported in part by grants from the Italian Association for Cancer Research (to M. L. V. and M. P.), by Ministero del lavoro e previdenza sociale N.792 (to A. P.), and by the Italian Ministry of University and Scientific and Technological Research (to M. L. V., M. P., and A. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
 To whom correspondence should be addressed. Tel.: 39-091-6577407; Fax: 39-091-6577430; E-mail: mlvitt{at}unipa.it.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. W. Kriebel, V. A. Barr, E. C. Rericha, G. Zhang, and C. A. Parent
Collective cell migration requires vesicular trafficking for chemoattractant delivery at the trailing edge
J. Cell Biol.,
December 1, 2008;
183(5):
949 - 961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Mellgren and X. Huang
Fetuin A Stabilizes m-Calpain and Facilitates Plasma Membrane Repair
J. Biol. Chem.,
December 7, 2007;
282(49):
35868 - 35877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Said, M. J. Socha, J. J. Olearczyk, A. A. Elmarakby, J. D. Imig, and K. Motamed
Normalization of the Ovarian Cancer Microenvironment by SPARC
Mol. Cancer Res.,
October 1, 2007;
5(10):
1015 - 1030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Aoki, S. Jin-no, Y. Nakagawa, N. Asai, E. Arakawa, N. Tamura, T. Tamura, and T. Matsuda
Identification and Characterization of Microvesicles Secreted by 3T3-L1 Adipocytes: Redox- and Hormone-Dependent Induction of Milk Fat Globule-Epidermal Growth Factor 8-Associated Microvesicles
Endocrinology,
August 1, 2007;
148(8):
3850 - 3862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Obregon, B. Rothen-Rutishauser, S. K. Gitahi, P. Gehr, and L. P. Nicod
Exovesicles from Human Activated Dendritic Cells Fuse with Resting Dendritic Cells, Allowing Them to Present Alloantigens
Am. J. Pathol.,
December 1, 2006;
169(6):
2127 - 2136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Lynes, K. Zaffuto, D. W. Unfricht, G. Marusov, J. S. Samson, and X. Yin
The physiological roles of extracellular metallothionein.
Experimental Biology and Medicine,
October 1, 2006;
231(9):
1548 - 1554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Li, H. Guo, X. Luo, J. Sheng, S. Yang, Y. Yin, J. Zhou, and J. Zhou
Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons
FASEB J,
June 1, 2006;
20(8):
1263 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Khalil, Y. D. Xu, R. O'Connor, and V. Duronio
Proliferation of Pulmonary Interstitial Fibroblasts Is Mediated by Transforming Growth Factor-beta1-induced Release of Extracellular Fibroblast Growth Factor-2 and Phosphorylation of p38 MAPK and JNK
J. Biol. Chem.,
December 30, 2005;
280(52):
43000 - 43009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bianco, E. Pravettoni, A. Colombo, U. Schenk, T. Moller, M. Matteoli, and C. Verderio
Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1{beta} Release from Microglia
J. Immunol.,
June 1, 2005;
174(11):
7268 - 7277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Kwabi-Addo, M Ozen, and M Ittmann
The role of fibroblast growth factors and their receptors in prostate cancer
Endocr. Relat. Cancer,
December 1, 2004;
11(4):
709 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Graves, E. V. Ariztia, J. R. Navari, H. J. Matzel, M. S. Stack, and D. A. Fishman
Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles
Cancer Res.,
October 1, 2004;
64(19):
7045 - 7049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kardami, Z.-S. Jiang, S. K Jimenez, C. J Hirst, F. Sheikh, P. Zahradka, and P. A Cattini
Fibroblast growth factor 2 isoforms and cardiac hypertrophy
Cardiovasc Res,
August 15, 2004;
63(3):
458 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Celis, P. Gromov, T. Cabezon, J. M. A. Moreira, N. Ambartsumian, K. Sandelin, F. Rank, and I. Gromova
Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment: A Novel Resource for Biomarker and Therapeutic Target Discovery
Mol. Cell. Proteomics,
April 1, 2004;
3(4):
327 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|